Mereo BioPharma Group

NASDAQ: MREO · Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 3:59 PM
1.74
0.00%
After-hours: Aug 15, 2025, 06:25 PM EDT

Mereo BioPharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 10M 1.51M 36.46M
Cost of Revenue
n/a 2.57M 936K 17.91M
Gross Profit
n/a 7.43M 571K 18.56M
Operating Income
-47.36M -28.42M -43.57M -20.94M
Interest Income
3.04M 2.13M 696K 1.38K
Pretax Income
-43.25M -30M -36.09M 14.24M
Net Income
-43.25M -29.47M -34.2M 12.72M
Selling & General & Admin
26.43M 18.42M 19.54M 15.93M
Research & Development
20.94M 17.42M 24.96M 23.56M
Other Expenses
n/a n/a 811K n/a
Operating Expenses
47.36M 35.84M 44.51M 39.49M
Interest Expense
1.37M 2.88M 3.36M 5.22M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 38.42M 43.57M 57.4M
Income Tax Expense
18.2K -532K -1.9M 1.52M
Shares Outstanding (Basic)
147.92M 131.89M 120.64M 116.73M
Shares Outstanding (Diluted)
147.92M 131.89M 120.64M 116.73M
EPS (Basic)
-0.29 -1.1K -1.75K 749.65
EPS (Diluted)
-0.29 -1.1K -1.75K 749.65
EBITDA
-47.36M -26.06M -42.06M -5M
EBIT
-44.62M -27.12M -32.73M 24.62M
Depreciation & Amortization
n/a 1.06M 1.51M 866.47K